Newly Discovered Target For Genital Herpes Vaccine

Researchers at the University of Gothenburg have identified glycoprotein G as a key protein that allows the genital herpes virus (HSV-2) to infect the nervous system, a discovery made through experiments on mice. This protein is now considered a promising target for developing a future vaccine against the widespread viral infection.
Researchers at the University of Gothenburg have identified a key protein that allows the virus that causes genital herpes to get into the nervous system. The discovery, made in experiments on mice, could pave the way for future vaccines against the disease.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in